Abstract: A stable micronized monoclinic form of asenapine maleate is described, which comprises 5% by weight or less of orthorhombic form or any other crystalline form of asenapine maleate, wherein the asenapine maleate has a particle size distribution characterized by a d90 equal to or below 40 ?m. Processes for preparing the stable micronized monoclinic form of asenapine maleate are also described. Formula (I).
Abstract: The present invention is directed to novel compounds of formula (I) as well as to the process for their preparation. Novel compounds of formula (I) can be converted into asenapine through an efficient process. The invention also relates to novel intermediates used in this process and their use in the preparation of compounds of formula (I).
Type:
Grant
Filed:
July 29, 2011
Date of Patent:
February 18, 2014
Assignee:
Laboratories Lesvi, S.L.
Inventors:
Pere Dalmases Barjoan, Juan Huguet Clotet, Jordi Peirats Masia